Article
Discovery and Characterization of Novel GPR39 Agonists Allosterically Modulated by Zinc.
Molecular pharmacology - 1 Dec 2016
Sato Seiji, Huang Xi-Ping, Kroeze Wesley K, Roth Bryan L
Abstract excerpt
In this study, we identified two previously described kinase inhibitors-3-(4-chloro-2-fluorobenzyl)-2-methyl-N-(3-methyl-1H-pyrazol-5-yl)-8-(morpholinomethyl)imidazo[1,2-b]pyridazin-6-amine (LY2784544) and 1H-benzimidazole-4-carboxylic acid, 2-methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-(4-morpholinyl)- (GSK2636771)-as novel GPR39 agonists by unbiased small-molecule-based screening using a β-arrestin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
